touchPODCAST

Advancing the management of adult solid tumours in 2023, and beyond: Unlocking the potential of radiopharmaceuticals

touchEXPERT OPINIONS for touchONCOLOGY

Leading experts share their insights on the role and use of radiopharmaceuticals in adult patients with solid tumours (with a focus on NETs and prostate cancer) and provide guidance for daily clinical practice to support their integration.

The experts:

Part 1 (00:00)

• Dr Stephen Graves, University of Iowa, Iowa City, IA, USA
• Dr Ana Kiess, Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Part 2 (20:20)

• Prof. Jorge Garcia, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA
• Dr Jason Starr, Mayo Clinic, Jacksonville, FL, USA
• Dr Erik Mittra, Oregon Health and Science University, Portland, OR, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A and is jointly provided by USF Health and touchIME.

For further information visit: https://touchoncologyime.org/radiopharmaceuticals-adult-oncology-primer

Current and future considerations for the use of immune checkpoint inhibitors in NSCLC

Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives.

The expert

• Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website:
touchONCOLOGY

Current and future considerations for the use of immune checkpoint inhibitors in NSCLC

Listen to a leading expert discuss the use of immune checkpoint inhibitors for the treatment of NSCLC, considering the current landscape and future perspectives.

The expert

• Dr Pilar Garrido – University Hospital Ramón y Cajal, Madrid, Spain
  

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck and Co., Inc. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website:
touchRESPIRATORY

Shaping ART around individual needs: Maximizing adherence and quality of life

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES

Listen to a panel of experts discuss the importance of optimizing antiretroviral therapy through an individualized approach to care and shared decision making. 

The experts

• Prof Jens Lundgren, University of Copenhagen, Hvidovre, Denmark
• Prof Marta Boffito, Chelsea and Westminster Hospital and Imperial College London, UK
• Ms Angelina Namiba, 4M Network, UK
  

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME. 

For further information visit:
https://touchinfectiousdiseases.com/

Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care

touchSATELLITE SYMPOSIUM for touchOPHTHALMOLOGY

Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers.

Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA).

The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed by audience Q&A (12:38).

The second session, led by Dr Jeffrey Bennett (15:57), discusses the latest efficacy and safety data on immunotherapies for NMOSD, and the factors influencing clinical decision making in daily practice. This is followed by audience Q&A (30:48).

In the third session, Dr Dalia Rotstein (34:49) summarizes the wider clinical symptoms of NMOSD and multidisciplinary strategies to mitigate the burden of disease. This is followed by a panel discussion in which the faculty provide their insights on selected Q&A from the audience (39:30).

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Alexion. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchophthalmologyime.org/nmosd-latest-developments/

Latest developments in neuromyelitis optica spectrum disorder (NMOSD): Diagnostics, treatments and patient-centered care

touchSATELLITE SYMPOSIUM for touchNEUROLOGY

Listen to this touch satellite symposium recorded live in June 2023 at the Annual Meeting of the Consortium of Multiple Sclerosis Centers.

Dr Dalia Rotstein (Canada), the chair for the symposium, is joined by Dr Eoin Flanagan (USA) and Dr Jeffrey Bennett (USA).

The first session, led by Dr Eoin Flanagan (03:55), focuses on the characterization of NMOSD, and the latest evidence-based strategies to achieve timely and accurate diagnosis. This is followed by audience Q&A (12:38).

The second session, led by Dr Jeffrey Bennett (15:57), discusses the latest efficacy and safety data on immunotherapies for NMOSD, and the factors influencing clinical decision making in daily practice. This is followed by audience Q&A (30:48).

In the third session, Dr Dalia Rotstein (34:49) summarizes the wider clinical symptoms of NMOSD and multidisciplinary strategies to mitigate the burden of disease. This is followed by a panel discussion in which the faculty provide their insights on selected Q&A from the audience (39:30).

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Alexion. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurologyime.org/nmosd-latest-developments/ 

Key considerations for treatment selection and sequencing in patients with RRMM: Lessons from real-life clinical practice

touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM.

The experts:

• Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA
• Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA
• Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchhaematologyime.org/

 

Key considerations for treatment selection and sequencing in patients with RRMM Lessons from real-life clinical practice

touchPANEL DISCUSSION for touchONCOLOGY 
Listen to a panel of leading experts discuss the key considerations for treatment selection and sequencing in patients with RRMM.

The experts:

• Dr Sarah Holstein, University of Nebraska Medical Center, Omaha, NE, USA
• Dr Nikhil Munshi, Dana-Farber Cancer Institute, Boston, MA, USA
• Dr Noopur Raje, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information please visit: https://touchoncology.com/

 

Individualizing long-term treatment and care in active MS

touchIN CONVERSATION for touchNEUROLOGY

Listen to Dr Ruth Dobson (Queen Mary University of London, UK) in conversation with Dr Ide Smets (MS Center ErasMS, Rotterdam, The Netherlands). They discuss questions submitted by the healthcare professional (HCP) audience and provide their expert insights on the practicalities of therapeutic sequencing options in multiple sclerosis (MS).

Clinical themes:

1. Factors guiding the use of high-efficacy disease-modifying therapies (DMTs) in the management of active MS (02:01)
2. Current approaches and safety considerations relating to DMT switching and sequencing in MS (14:17)
3. Approaches needed to support women of child-bearing age living with MS through family planning and beyond (23:38)

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchneurology.com/individualizing-long-term-treatment-and-care-in-MS/

MDT perspectives on approaches for the use of immune checkpoint inhibitor therapy in patients with solid tumours

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team evaluate the strategies for identifying and monitoring immune-related adverse events.

The multidisciplinary team:

• Medical oncologist: Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
• Oncology nurse: Ms Tara Hurley, Royal Marsden NHS Foundation Trust, Sutton, UK
• Clinical oncology pharmacist: Dr Alison Palumbo, Oregon Health and Science University, Oregon, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from MSD. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/immune-checkpoint-inhibitors-in-solid-tumours/